<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37240639</PMID><DateRevised><Year>2023</Year><Month>05</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>10</Issue><PubDate><Year>2023</Year><Month>May</Month><Day>18</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>Manifestation of Headache Affecting Quality of Life in Long COVID Patients.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">3533</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm12103533</ELocationID><Abstract><AbstractText><b>Objectives</b>: The present study aimed to elucidate the characteristics of long COVID patients with headaches. <b>Methods</b>: A single-center retrospective observational study was performed for long COVID outpatients who visited our hospital from 12 February 2021 to 30 November 2022. <b>Results</b>: A total of 482 long COVID patients, after excluding 6, were divided into two groups: the Headache group of patients with complaints of headache (113 patients: 23.4%) and the remaining Headache-free group. Patients in the Headache group were younger (median age: 37 years) than patients in the Headache-free group (42 years), while the ratio of females (56%) in the Headache group was nearly the same as that in the Headache-free group (54%). The proportion of patients in the Headache group who were infected in the Omicron-dominant phase (61%) was larger than the proportions of patients infected in the Delta (24%) and preceding (15%) phases, and that trend was significantly different from the trend in the Headache-free group. The duration before the first visit for long COVID was shorter in the Headache group (71 days) than in the Headache-free group (84 days). The proportions of patients in the Headache group with comorbid symptoms, including general fatigue (76.1%), insomnia (36.3%), dizziness (16.8%), fever (9.7%), and chest pain (5.3%) were larger than the proportions of patients in the Headache-free group, whereas blood biochemical data were not significantly different between the two groups. Interestingly, patients in the Headache group had significant deteriorations of scores indicating depression and scores for quality of life and general fatigue. In multivariate analysis, headache, insomnia, dizziness, lethargy, and numbness were shown to be involved in the quality of life (QOL) of long COVID patients. <b>Conclusions</b>: The manifestation of headaches related to long COVID was found to have a significant impact on social and psychological activities. Alleviation of headaches should be a priority for the effective treatment of long COVID.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fujita</LastName><ForeName>Kana</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-3437-8813</Identifier><AffiliationInfo><Affiliation>Department of General Medicine, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama 700-8558, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Otsuka</LastName><ForeName>Yuki</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0001-6015-6128</Identifier><AffiliationInfo><Affiliation>Department of General Medicine, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama 700-8558, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sunada</LastName><ForeName>Naruhiko</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama 700-8558, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Honda</LastName><ForeName>Hiroyuki</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0001-6098-5006</Identifier><AffiliationInfo><Affiliation>Department of General Medicine, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama 700-8558, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tokumasu</LastName><ForeName>Kazuki</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-9513-6864</Identifier><AffiliationInfo><Affiliation>Department of General Medicine, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama 700-8558, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakano</LastName><ForeName>Yasuhiro</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0001-9972-791X</Identifier><AffiliationInfo><Affiliation>Department of General Medicine, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama 700-8558, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sakurada</LastName><ForeName>Yasue</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama 700-8558, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Obika</LastName><ForeName>Mikako</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama 700-8558, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hagiya</LastName><ForeName>Hideharu</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-5086-1891</Identifier><AffiliationInfo><Affiliation>Department of General Medicine, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama 700-8558, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Otsuka</LastName><ForeName>Fumio</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0001-7014-9095</Identifier><AffiliationInfo><Affiliation>Department of General Medicine, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama 700-8558, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>JP22K20927 (Y.O.)</GrantID><Agency>Japan Society for the Promotion of Science</Agency><Country/></Grant><Grant><GrantID>2022 (F.O.).</GrantID><Agency>Ryobi Teien Memory Foundation</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19 aftercare clinic (CAC)</Keyword><Keyword MajorTopicYN="N">headache</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">post COVID-19 condition (PCC)</Keyword><Keyword MajorTopicYN="N">quality of life (QOL)</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>5</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>27</Day><Hour>9</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>27</Day><Hour>9</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>27</Day><Hour>1</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37240639</ArticleId><ArticleId IdType="pmc">PMC10219375</ArticleId><ArticleId IdType="doi">10.3390/jcm12103533</ArticleId><ArticleId IdType="pii">jcm12103533</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Soriano J.B., Murthy S., Marshall J.C., Relan P., Diaz J.V., on behalf of theWHO Clinical Case Definition Working Group on Post-COVID-19 Condition A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect. Dis. 2022;22:e102&#x2013;e107. doi: 10.1016/S1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballering A.V., van Zon S.K.R., Olde Hartman T.C., Rosmalen J.G.M. Persistence of somatic symptoms after COVID-19 in the Netherlands: An observational cohort study. Lancet. 2022;400:452&#x2013;461. doi: 10.1016/S0140-6736(22)01214-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01214-4</ArticleId><ArticleId IdType="pmc">PMC9352274</ArticleId><ArticleId IdType="pubmed">35934007</ArticleId></ArticleIdList></Reference><Reference><Citation>Sunada N., Honda H., Nakano Y., Yamamoto K., Tokumasu K., Sakurada Y., Matsuda Y., Hasegawa T., Otsuka Y., Obika M., et al. Hormonal trends in patients suffering from long COVID symptoms. Endocr. J. 2022;69:1173&#x2013;1181. doi: 10.1507/endocrj.EJ22-0093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1507/endocrj.EJ22-0093</ArticleId><ArticleId IdType="pubmed">35491089</ArticleId></ArticleIdList></Reference><Reference><Citation>Tokumasu K., Honda H., Sunada N., Sakurada Y., Matsuda Y., Yamamoto K., Nakano Y., Hasegawa T., Yamamoto Y., Otsuka Y., et al. Clinical Characteristics of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Diagnosed in Patients with Long COVID. Medicina. 2022;58:850. doi: 10.3390/medicina58070850.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina58070850</ArticleId><ArticleId IdType="pmc">PMC9325226</ArticleId><ArticleId IdType="pubmed">35888568</ArticleId></ArticleIdList></Reference><Reference><Citation>Otsuka Y., Tokumasu K., Nakano Y., Honda H., Sakurada Y., Sunada N., Omura D., Hasegawa K., Hagiya H., Obika M., et al. Clinical Characteristics of Japanese Patients Who Visited a COVID-19 Aftercare Clinic for Post-Acute Sequelae of COVID-19/Long COVID. Cureus. 2021;13:e18568. doi: 10.7759/cureus.18568.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.18568</ArticleId><ArticleId IdType="pmc">PMC8571943</ArticleId><ArticleId IdType="pubmed">34760415</ArticleId></ArticleIdList></Reference><Reference><Citation>Sunada N., Nakano Y., Otsuka Y., Tokumasu K., Honda H., Sakurada Y., Matsuda Y., Hasegawa T., Omura D., Ochi K., et al. Characteristics of Sleep Disturbance in Patients with Long COVID: A Retrospective Observational Study in Japan. J. Clin. Med. 2022;11:7332. doi: 10.3390/jcm11247332.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11247332</ArticleId><ArticleId IdType="pmc">PMC9783729</ArticleId><ArticleId IdType="pubmed">36555948</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuda Y., Tokumasu K., Otsuka Y., Sunada N., Honda H., Sakurada Y., Nakano Y., Hasegawa T., Obika M., Ueda K., et al. Symptomatic Characteristics of Hypozincemia Detected in Long COVID Patients. J. Clin. Med. 2023;12:2062. doi: 10.3390/jcm12052062.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12052062</ArticleId><ArticleId IdType="pmc">PMC10004579</ArticleId><ArticleId IdType="pubmed">36902849</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakano Y., Otsuka Y., Honda H., Sunada N., Tokumasu K., Sakurada Y., Matsuda Y., Hasegawa T., Ochi K., Hagiya H., et al. Transitional Changes in Fatigue-Related Symptoms Due to Long COVID: A Single-Center Retrospective Observational Study in Japan. Medicina. 2022;58:1393. doi: 10.3390/medicina58101393.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina58101393</ArticleId><ArticleId IdType="pmc">PMC9611667</ArticleId><ArticleId IdType="pubmed">36295554</ArticleId></ArticleIdList></Reference><Reference><Citation>Aparisi A., Ybarra-Falcon C., Iglesias-Echeverria C., Garcia-Gomez M., Marcos-Mangas M., Valle-Penacoba G., Carrasco-Moraleja M., Fernandez-de-Las-Penas C., Guerrero A.L., Garcia-Azorin D. Cardio-Pulmonary Dysfunction Evaluation in Patients with Persistent Post-COVID-19 Headache. Int. J. Environ. Res. Public Health. 2022;19:3961. doi: 10.3390/ijerph19073961.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19073961</ArticleId><ArticleId IdType="pmc">PMC8997887</ArticleId><ArticleId IdType="pubmed">35409644</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakurada Y., Otsuka Y., Tokumasu K., Sunada N., Honda H., Nakano Y., Matsuda Y., Hasegawa T., Ochi K., Hagiya H., et al. Trends in Long COVID Symptoms in Japanese Teenage Patients. Medicina. 2023;59:261. doi: 10.3390/medicina59020261.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina59020261</ArticleId><ArticleId IdType="pmc">PMC9964697</ArticleId><ArticleId IdType="pubmed">36837463</ArticleId></ArticleIdList></Reference><Reference><Citation>Tana C., Bentivegna E., Cho S.J., Harriott A.M., Garcia-Azorin D., Labastida-Ramirez A., Ornello R., Raffaelli B., Beltran E.R., Ruscheweyh R., et al. Long COVID headache. J. Headache Pain. 2022;23:93. doi: 10.1186/s10194-022-01450-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10194-022-01450-8</ArticleId><ArticleId IdType="pmc">PMC9340759</ArticleId><ArticleId IdType="pubmed">35915417</ArticleId></ArticleIdList></Reference><Reference><Citation>Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38:1&#x2013;211. doi: 10.1177/0333102417738202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0333102417738202</ArticleId><ArticleId IdType="pubmed">29368949</ArticleId></ArticleIdList></Reference><Reference><Citation>Mutiawati E., Kusuma H.I., Fahriani M., Harapan H., Syahrul S., Musadir N. Headache in Post-COVID-19 Patients: Its Characteristics and Relationship with the Quality of Life. Medicina. 2022;58:1500. doi: 10.3390/medicina58101500.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina58101500</ArticleId><ArticleId IdType="pmc">PMC9609032</ArticleId><ArticleId IdType="pubmed">36295660</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Tallawy S.N., Perglozzi J.V., Ahmed R.S., Kaki A.M., Nagiub M.S., LeQuang J.K., Hadarah M.M. Pain Management in the Post-COVID Era-An Update: A Narrative Review. Pain Ther. 2023;12:423&#x2013;448. doi: 10.1007/s40122-023-00486-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40122-023-00486-1</ArticleId><ArticleId IdType="pmc">PMC9971680</ArticleId><ArticleId IdType="pubmed">36853484</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Tallawy S.N., Nalamasu R., Pergolizzi J.V., Gharibo C. Pain Management During the COVID-19 Pandemic. Pain Ther. 2020;9:453&#x2013;466. doi: 10.1007/s40122-020-00190-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40122-020-00190-4</ArticleId><ArticleId IdType="pmc">PMC7445106</ArticleId><ArticleId IdType="pubmed">32840756</ArticleId></ArticleIdList></Reference><Reference><Citation>Siso-Almirall A., Brito-Zeron P., Conangla Ferrin L., Kostov B., Moragas Moreno A., Mestres J., Sellares J., Galindo G., Morera R., Basora J., et al. Long Covid-19: Proposed Primary Care Clinical Guidelines for Diagnosis and Disease Management. Int. J. Environ. Res. Public Health. 2021;18:4350. doi: 10.3390/ijerph18084350.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18084350</ArticleId><ArticleId IdType="pmc">PMC8073248</ArticleId><ArticleId IdType="pubmed">33923972</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato Y. Case Management of COVID-19 (Secondary Version) JMA J. 2021;4:191&#x2013;197. doi: 10.31662/jmaj.2021-0036.</Citation><ArticleIdList><ArticleId IdType="doi">10.31662/jmaj.2021-0036</ArticleId><ArticleId IdType="pmc">PMC8355701</ArticleId><ArticleId IdType="pubmed">34414312</ArticleId></ArticleIdList></Reference><Reference><Citation>Zung W.W. A Self-Rating Depression Scale. Arch. Gen. Psychiatry. 1965;12:63&#x2013;70. doi: 10.1001/archpsyc.1965.01720310065008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archpsyc.1965.01720310065008</ArticleId><ArticleId IdType="pubmed">14221692</ArticleId></ArticleIdList></Reference><Reference><Citation>Kusano M., Shimoyama Y., Sugimoto S., Kawamura O., Maeda M., Minashi K., Kuribayashi S., Higuchi T., Zai H., Ino K., et al. Development and evaluation of FSSG: Frequency scale for the symptoms of GERD. J. Gastroenterol. 2004;39:888&#x2013;891. doi: 10.1007/s00535-004-1417-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00535-004-1417-7</ArticleId><ArticleId IdType="pubmed">15565409</ArticleId></ArticleIdList></Reference><Reference><Citation>De Vries J., Michielsen H., Van Heck G.L., Drent M. Measuring fatigue in sarcoidosis: The Fatigue Assessment Scale (FAS) Br. J. Health Psychol. 2004;9:279&#x2013;291. doi: 10.1348/1359107041557048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1348/1359107041557048</ArticleId><ArticleId IdType="pubmed">15296678</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiroiwa T., Ikeda S., Noto S., Igarashi A., Fukuda T., Saito S., Shimozuma K. Comparison of Value Set Based on DCE and/or TTO Data: Scoring for EQ-5D-5L Health States in Japan. Value Health. 2016;19:648&#x2013;654. doi: 10.1016/j.jval.2016.03.1834.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jval.2016.03.1834</ArticleId><ArticleId IdType="pubmed">27565282</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikeda S., Shiroiwa T., Igarashi A., Noto S., Fukuda T., Saito S., Shimozuma K. Developing a Japanese version of the EQ-5D-5L value set. J. Natl. Inst. Public Health. 2015;64:47&#x2013;55.</Citation></Reference><Reference><Citation>Kanda Y. Investigation of the freely available easy-to-use software &#x2018;EZR&#x2019; for medical statistics. Bone Marrow Transpl. 2013;48:452&#x2013;458. doi: 10.1038/bmt.2012.244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/bmt.2012.244</ArticleId><ArticleId IdType="pmc">PMC3590441</ArticleId><ArticleId IdType="pubmed">23208313</ArticleId></ArticleIdList></Reference><Reference><Citation>von Elm E., Altman D.G., Egger M., Pocock S.J., Gotzsche P.C., Vandenbroucke J.P., Initiative S. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. BMJ. 2007;335:806&#x2013;808. doi: 10.1136/bmj.39335.541782.AD.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.39335.541782.AD</ArticleId><ArticleId IdType="pmc">PMC2034723</ArticleId><ArticleId IdType="pubmed">17947786</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-de-Las-Penas C., Navarro-Santana M., Gomez-Mayordomo V., Cuadrado M.L., Garcia-Azorin D., Arendt-Nielsen L., Plaza-Manzano G. Headache as an acute and post-COVID-19 symptom in COVID-19 survivors: A meta-analysis of the current literature. Eur. J. Neurol. 2021;28:3820&#x2013;3825. doi: 10.1111/ene.15040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.15040</ArticleId><ArticleId IdType="pmc">PMC8444899</ArticleId><ArticleId IdType="pubmed">34327787</ArticleId></ArticleIdList></Reference><Reference><Citation>Martelletti P., Bentivegna E., Luciani M., Spuntarelli V. Headache as a Prognostic Factor for COVID-19. Time to Re-evaluate. SN Compr. Clin. Med. 2020;2:2509&#x2013;2510. doi: 10.1007/s42399-020-00657-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42399-020-00657-7</ArticleId><ArticleId IdType="pmc">PMC7690334</ArticleId><ArticleId IdType="pubmed">33263101</ArticleId></ArticleIdList></Reference><Reference><Citation>Pullen M.F., Skipper C.P., Hullsiek K.H., Bangdiwala A.S., Pastick K.A., Okafor E.C., Lofgren S.M., Rajasingham R., Engen N.W., Galdys A., et al. Symptoms of COVID-19 Outpatients in the United States. Open Forum. Infect. Dis. 2020;7:ofaa271. doi: 10.1093/ofid/ofaa271.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofaa271</ArticleId><ArticleId IdType="pmc">PMC7337847</ArticleId><ArticleId IdType="pubmed">33117855</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Hashel J.Y., Abokalawa F., Alenzi M., Alroughani R., Ahmed S.F. Coronavirus disease-19 and headache; impact on pre-existing and characteristics of de novo: A cross-sectional study. J. Headache Pain. 2021;22:97. doi: 10.1186/s10194-021-01314-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10194-021-01314-7</ArticleId><ArticleId IdType="pmc">PMC8380111</ArticleId><ArticleId IdType="pubmed">34418950</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker W.J., Findlay T., Moga C., Scott N.A., Harstall C., Taenzer P. Guideline for primary care management of headache in adults. Can. Fam. Physician. 2015;61:670&#x2013;679.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4541429</ArticleId><ArticleId IdType="pubmed">26273080</ArticleId></ArticleIdList></Reference><Reference><Citation>Dodick D.W. Pearls: Headache. Semin. Neurol. 2010;30:74&#x2013;81. doi: 10.1055/s-0029-1245000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0029-1245000</ArticleId><ArticleId IdType="pubmed">20127586</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitsikostas D.D., Ashina M., Craven A., Diener H.C., Goadsby P.J., Ferrari M.D., Lampl C., Paemeleire K., Pascual J., Siva A., et al. European Headache Federation consensus on technical investigation for primary headache disorders. J. Headache Pain. 2015;17:5. doi: 10.1186/s10194-016-0596-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10194-016-0596-y</ArticleId><ArticleId IdType="pmc">PMC4747925</ArticleId><ArticleId IdType="pubmed">26857820</ArticleId></ArticleIdList></Reference><Reference><Citation>Lippi G., Mattiuzzi C., Bovo C., Henry B.M. Headache is an important symptom in patients with coronavirus disease 2019 (COVID-19) Diagnosis. 2020;7:409&#x2013;411. doi: 10.1515/dx-2020-0048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/dx-2020-0048</ArticleId><ArticleId IdType="pubmed">32478675</ArticleId></ArticleIdList></Reference><Reference><Citation>Caronna E., Ballve A., Llaurado A., Gallardo V.J., Ariton D.M., Lallana S., Lopez Maza S., Olive Gadea M., Quibus L., Restrepo J.L., et al. Headache: A striking prodromal and persistent symptom, predictive of COVID-19 clinical evolution. Cephalalgia. 2020;40:1410&#x2013;1421. doi: 10.1177/0333102420965157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0333102420965157</ArticleId><ArticleId IdType="pmc">PMC7645597</ArticleId><ArticleId IdType="pubmed">33146036</ArticleId></ArticleIdList></Reference><Reference><Citation>Trigo J., Garcia-Azorin D., Planchuelo-Gomez A., Martinez-Pias E., Talavera B., Hernandez-Perez I., Valle-Penacoba G., Simon-Campo P., de Lera M., Chavarria-Miranda A., et al. Factors associated with the presence of headache in hospitalized COVID-19 patients and impact on prognosis: A retrospective cohort study. J. Headache Pain. 2020;21:94. doi: 10.1186/s10194-020-01165-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10194-020-01165-8</ArticleId><ArticleId IdType="pmc">PMC7388434</ArticleId><ArticleId IdType="pubmed">32727345</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>